Pearlshine Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.00 M
About Pearlshine Lifescience
Pearlshine Lifescience Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 May 2013 and has a history of 11 years and nine months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Sajanish Meyath, Praveen, Abhilash Vijayan, and One other member serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52100KA2013PTC068857
- Company No.
068857
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 May 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
What products or services does Pearlshine Lifescience Private Limited offer?
Pearlshine Lifescience Private Limited offers a wide range of products and services, including Health Conditions, Pain Relief.
Who are the key members and board of directors at Pearlshine Lifescience?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajanish Meyath  | Director | 23-Oct-2015 | Current |
| Praveen | Director | 03-Jul-2017 | Current |
| Abhilash Vijayan | Director | 20-May-2016 | Current |
| Maniyil Vinod | Director | 20-May-2016 | Current |
Financial Performance of Pearlshine Lifescience.
Pearlshine Lifescience Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Pearlshine Lifescience?
In 2017, Pearlshine Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2017 | Others | ₹1.00 M | Open |
How Many Employees Work at Pearlshine Lifescience?
Unlock and access historical data on people associated with Pearlshine Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pearlshine Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pearlshine Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
